By binding to the intestinal FXR, bile acids can induce the expression of endocrine hormone fibroblast growth factor 19 (FGF19), which suppresses lipogenesis and increases fatty acid oxidation in the liver, thereby regulating body weight gain and reducing the risk of obesity [48]. Here, FGF19 is linked to obesity disorder.